NCT06530485

Brief Summary

The goal of this study is to evaluate the efficacy of microbiota-directed food in comparison to zinc with micronutrient powder and Khichuri on changes in circulating immune cells (monocytes, T cells, B cells, and NK cells) in malnourished children after recovery from acute infection. The study aims to answer the research question: Does microbiota-directed food (MDF) compared to zinc with micronutrient powder (MNP) and Khichuri therapy enhance immunity in children with severe acute malnutrition? The researcher will compare the effectiveness of microbiota-directed food (MDF) versus zinc with micronutrient powder (MNP) and Khichuri therapy to see if MDF enhances immunity in severely malnourished children. Severely malnourished children will:

  • Receive microbiota-directed food (MDF) or zinc with micronutrient powder (MNP) and Khichuri every day for 12 weeks.
  • Phenotyping of circulating immune cells (NK cells, T cells, B cells) will be conducted using flow cytometry and fluorescence-activated cell sorting techniques.

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Aug 2024

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 28, 2024

Completed
3 days until next milestone

First Posted

Study publicly available on registry

July 31, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

August 1, 2024

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 2, 2024

Status Verified

June 1, 2024

Enrollment Period

1.4 years

First QC Date

July 28, 2024

Last Update Submit

July 31, 2024

Conditions

Keywords

ImmunityMalnutritionMicrobiota-directed food (MDF)ZincNK cellsGut microbiota

Outcome Measures

Primary Outcomes (1)

  • NK cells

    Differences in the proportion and activity of circulating NK cells between the groups 12 weeks after the intervention, measured by flow cytometry/fluorescence-assisted cell sorter (FACS).

    12 weeks

Secondary Outcomes (8)

  • Circulating immune cells

    12 weeks

  • Cytokines and chemokines

    12 weeks

  • Micro biocidal capacity

    12 weeks

  • Rate of weight gain

    12 weeks

  • Diarrhea and pneumonia

    12 weeks

  • +3 more secondary outcomes

Study Arms (2)

Microbiota-directed food

EXPERIMENTAL

Children randomized to this group will receive Microbiota-directed food (MDF) daily for 12 weeks. MDF can modulate the gut microbiota and enhance host immunity, growth, and development in malnourished children.

Dietary Supplement: Microbiota-directed food

Khichuri

ACTIVE COMPARATOR

Children randomized to this group will receive zinc with Micronutrient powder (MNP) and Khichuri daily for 12 weeks.

Dietary Supplement: Khichuri

Interventions

Microbiota-directed foodDIETARY_SUPPLEMENT

MDF can modulate the gut microbiota and enhance host immunity, growth, and development in malnourished children. Each sachet of MDF (100 gm) provides approximately 500 kcal.

Also known as: MDF
Microbiota-directed food
KhichuriDIETARY_SUPPLEMENT

Khichuri is a home-based nutritious food with high energy and protein. This arm also contains zinc (10 gm/day), micronutrient powder, and an egg daily.

Also known as: Locally available food
Khichuri

Eligibility Criteria

Age6 Months - 36 Months
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Children aged 6 months to 36 months, and
  • Severe acute malnutrition as evident by weight-for-length z-score (WLZ) \< -3 and or mid-upper arm circumference (MUAC) \< 11.5 cm, and or edema of both feet, and
  • Completed the acute phase management for SAM and stayed at NRU for 7±4 days, with no medical complications, e.g. lethargic/unconscious, convulsions, unable to drink, persistent vomiting, respiratory distress.
  • Residing within the Dhaka district.
  • Parents/guardians provided written informed consent.

You may not qualify if:

  • WLZ ≥ -3 or MUAC ≥11.5 cm.
  • Presence of lethargy/unconsciousness, convulsions, unable to drink, persistent vomiting, respiratory distress.
  • Participants who receive multiple courses of antibiotic (\>2 courses during acute phase) treatment for a prolonged period (\>14 days).
  • Persistent diarrhea (≥14 days).
  • Chronic illness or disability affecting food intake, e.g. TB, HIV, congenital defects, cerebral palsy
  • Treated for SAM in the previous 3 months.
  • Known case of soy, peanut, or milk protein allergy.
  • Any sibling of the enrolled child.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Child Nutrition DisordersMalnutrition

Interventions

milk-derived factor

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Farzana Afroze

    International Centre for Diarrhoeal Disease Research, Bangladesh

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Farzana Afroze, MBBS, FCPS

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 28, 2024

First Posted

July 31, 2024

Study Start

August 1, 2024

Primary Completion

December 31, 2025

Study Completion

December 31, 2025

Last Updated

August 2, 2024

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share